Home

David J. Endicott

CIK 1532133 · Pres., Hospira Medical Devices · last filed 2017-07-18

David J. Endicott is a Pres., Hospira Medical Devices who has filed 19 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing, for ALC, was dated Sep 12, 2024. Across all open-market trades the lifetime net is −$7.6M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

19

Lifetime Open-Market Net

-$7.62M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Orexigen Therapeutics, Inc. (OREX) Delisted Director — — — $0 6 2017-07-18
Zeltiq Aesthetics Inc (ZLTQ) Delisted Director 0 — — $0 3 2017-04-28
HOSPIRA INC (HSP) Delisted Pres., Hospira Medical Devices 205,668 — — $0 2 2015-09-03
ALLERGAN INC (AGN) Delisted CVP and President, AGN Med 20,448 — — -$7.62M 7 2013-02-22

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-09-12 ALC Notice (144) −112,182 -$11.27M EDGAR
2017-07-18 Orexigen Therapeutics, Inc. (OREX) Delisted Grant (A) — $0 EDGAR
2017-04-28 Zeltiq Aesthetics Inc (ZLTQ) Delisted Other (J) −16,132 $0 EDGAR
2016-07-14 Orexigen Therapeutics, Inc. (OREX) Delisted Grant (A) — $0 EDGAR
2016-06-23 Zeltiq Aesthetics Inc (ZLTQ) Delisted Grant (A) +6,199 $175.0K EDGAR
2016-04-26 Zeltiq Aesthetics Inc (ZLTQ) Delisted Grant (A) +9,933 $0 EDGAR
2015-09-03 HOSPIRA INC (HSP) Delisted Mixed −117,501 -$15.37M EDGAR
2015-06-10 Orexigen Therapeutics, Inc. (OREX) Delisted Grant (A) — $0 EDGAR
2015-02-27 HOSPIRA INC (HSP) Delisted Grant (A) +40,000 $3.50M EDGAR
2013-08-28 Orexigen Therapeutics, Inc. (OREX) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.